A detailed history of Daiwa Securities Group Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 754 shares of ARDX stock, worth $3,445. This represents 0.0% of its overall portfolio holdings.

Number of Shares
754
Previous 754 -0.0%
Holding current value
$3,445
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$1.22 - $2.85 $919 - $2,148
754 New
754 $2,000
Q4 2021

Feb 03, 2022

SELL
$0.86 - $1.7 $168 - $333
-196 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$5.05 - $7.1 $1,504 - $2,115
-298 Reduced 60.32%
196 $1,000
Q1 2020

May 14, 2020

BUY
$4.35 - $8.79 $604 - $1,221
139 Added 39.15%
494 $3,000
Q4 2019

Jan 31, 2020

BUY
$4.23 - $8.29 $1,501 - $2,942
355 New
355 $3,000
Q4 2018

Feb 05, 2019

SELL
$1.66 - $4.16 $436 - $1,094
-263 Closed
0 $0
Q1 2018

May 02, 2018

BUY
$5.05 - $7.9 $1,328 - $2,077
263 New
263 $1,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $707M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.